BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7521439)

  • 1. [Interferon-associated retinopathy].
    Okuno H; Hirota T; Shiozaki Y; Inoue K; Hagihara M; Sugasawa K; Okami T
    Nihon Rinsho; 1994 Jul; 52(7):1919-23. PubMed ID: 7521439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pegylated-interferon-associated retinopathy in chronic hepatitis patients.
    Lim JW; Shin MC
    Ophthalmologica; 2010; 224(4):224-9. PubMed ID: 19940529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interferon-associated retinopathy].
    Hararda T; Fukami H; Takeuchi T; Niwa T; Majima Y
    Klin Monbl Augenheilkd; 1995 Nov; 207(5):302-4. PubMed ID: 8587306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinopathy associated with pegylated interferon and ribavirin causing permanent visual impairment in a patient with chronic hepatitis C.
    Moisseiev E; Goldenberg D; Kurtz S
    Ophthalmic Surg Lasers Imaging; 2011 Sep; 42 Online():e91-3. PubMed ID: 21899250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ophthalmologic side effects during alpha-interferon therapy for viral hepatitis.
    d'Alteroche L; Majzoub S; Lecuyer AI; Delplace MP; Bacq Y
    J Hepatol; 2006 Jan; 44(1):56-61. PubMed ID: 16223542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal complications during interferon therapy for chronic hepatitis C.
    Kawano T; Shigehira M; Uto H; Nakama T; Kato J; Hayashi K; Maruyama T; Kuribayashi T; Chuman T; Futami T; Tsubouchi H
    Am J Gastroenterol; 1996 Feb; 91(2):309-13. PubMed ID: 8607498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interferon-induced retinal changes].
    Chuman T; Nao-i N; Sawada A; Kawano T; Shigehira M
    Nippon Ganka Gakkai Zasshi; 1994 Jun; 98(6):616-21. PubMed ID: 7518188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C and interferon-associated retinopathy: a case report.
    Van Wie AM
    Optometry; 2011 Dec; 82(12):739-43. PubMed ID: 22108545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Depression during interferon therapy in chronic hepatitis C patients--a prospective study].
    Otsubo T; Miyaoka H; Kamijima K; Onuki M; Ishii M; Mitamura K
    Seishin Shinkeigaku Zasshi; 1997; 99(3):101-27. PubMed ID: 9136611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinal complications and plasma C5a levels during interferon alpha therapy for chronic hepatitis C.
    Sugano S; Suzuki T; Watanabe M; Ohe K; Ishii K; Okajima T
    Am J Gastroenterol; 1998 Dec; 93(12):2441-4. PubMed ID: 9860406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of risk factors of interferon-associated retinopathy in patients with type C chronic active hepatitis].
    Soushi S; Kobayashi F; Obazawa H; Kigasawa K; Shiraishi K; Itakura M; Matsuzaki S
    Nippon Ganka Gakkai Zasshi; 1996 Jan; 100(1):69-76. PubMed ID: 8644532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical course of macular edema in two cases of interferon-associated retinopathy observed by optical coherence tomography.
    Shimura M; Saito T; Yasuda K; Tamai M
    Jpn J Ophthalmol; 2005; 49(3):231-4. PubMed ID: 15944830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal lesions as clues to disseminated bacterial and candidal infections: frequency, natural history, and etiology.
    Rodríguez-Adrián LJ; King RT; Tamayo-Derat LG; Miller JW; Garcia CA; Rex JH
    Medicine (Baltimore); 2003 May; 82(3):187-202. PubMed ID: 12792305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics of hepatitis C virus-associated retinopathy.
    Abe T; Nakajima A; Satoh N; Koizumi T; Sakuragi S; Ono T; Komatsu M; Masamune O
    Jpn J Ophthalmol; 1995; 39(4):411-9. PubMed ID: 8926649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interstitial pneumonia induced by interferon therapy in type C hepatitis].
    Karino Y; Hige S; Matsushima T; Toyota J
    Nihon Rinsho; 1994 Jul; 52(7):1905-9. PubMed ID: 7521437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Retinopathy secondary to treatment with Interferon beta-1a in a patient with multiple sclerosis].
    Mallada-Frechín J; Abellán-Miralles I; Alfaro-Beltra ML; Medrano V; Muñoz-Gil MB; Fernández-Izquierdo S; Piqueras-Rodríguez L
    Rev Neurol; 2005 Apr 16-30; 40(8):482-4. PubMed ID: 15861330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case report of interferon-associated retinopathy].
    Sobolewski P; Lapiński T
    Klin Oczna; 1999; 101(3):213-6. PubMed ID: 10526448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiovascular complications of interferon therapy in chronic hepatitis C].
    Kouno H; Aimitsu S; Ikemoto Y; Nakanishi T; Kajiyama G
    Nihon Rinsho; 1994 Jul; 52(7):1914-8. PubMed ID: 7521438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transient retinopathy after acute myocardial infarction treated by reperfusion therapy: clinical background and manifestation].
    Katayama T; Yasu T; Kinoshita N; Kakehashi A; Ueba H; Hashimoto S; Kobayashi N; Tsuruya Y; Kubo N; Fujii M; Kuroki M; Kawakami M; Saito M
    J Cardiol; 2003 Jul; 42(1):23-8. PubMed ID: 12892038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interferon-beta retinopathy].
    Sallansonnet-Froment M; Roux X; de Greslan T; Bounolleau P; Taillia H; Ricard D; Ouologuem M; Renard JL
    Rev Neurol (Paris); 2009 Nov; 165(11):971-4. PubMed ID: 19147167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.